微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.44% | 5.46% | 60.87% | 6/52 | 1.36% | 诺泰生物 | 14.63% | 行业排名> |
| 2024-06-30 | 2.76% | -13.21% | 93.01% | 17/52 | 2.24% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.43% | -28.86% | -69.89% | 18/52 | 1.22% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 4.75% | 5.79% | 12.83% | 25/52 | 3.83% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 4.21% | 2% | 32.39% | 29/52 | 6.78% | 澳洋健康 | 61.89% | 行业排名> |
| 2023-06-30 | 3.18% | 21.84% | 58.21% | 25/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.01% | 2% | -55.23% | 21/52 | 2.55% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 4.49% | -34.16% | 72.03% | 30/52 | -0.52% | *ST宜康 | 75.53% | 行业排名> |
| 2022-06-30 | 2.61% | -39.86% | -61.73% | 30/52 | 5.46% | 博腾股份 | 39.77% | 行业排名> |
| 2021-12-31 | 6.82% | -5.8% | 57.14% | 34/52 | -6.4% | 睿智医药 | 41.16% | 行业排名> |
| 2021-06-30 | 4.34% | 17.93% | -40.06% | 29/52 | 2.32% | 澳洋健康 | 51.68% | 行业排名> |
| 2020-12-31 | 7.24% | -41.75% | 96.74% | 35/52 | 10.94% | 澳洋健康 | 40.93% | 行业排名> |
| 2020-06-30 | 3.68% | 2% | -70.39% | 22/52 | 2.51% | 金域医学 | 43.58% | 行业排名> |
| 2019-12-31 | 12.43% | 3.67% | 3.67% | 23/52 | 64.11% | 金域医学 | 35.41% | 行业排名> |
| 2018-12-31 | 11.99% | -24.5% | -24.5% | 21/52 | -0.5% | 阳光诺和 | 26.2% | 行业排名> |
| 2017-12-31 | 15.88% | 2% | 2% | 10/52 | 2.03% | 金域医学 | 13.23% | 行业排名> |